Respiratory Syncytial Virus: A Year of Infant Protection Breakthroughs
The world's first maternal vaccine against RSV in neonates and infants was approved in August. This brief slide show highlights the clinical trials that made history.
A vaccine against respiratory syncytial virus for newborns and young infants has been elusive since a clinical trial in the mid-1960s that resulted in nearly all the study participants being hospitalized with the infection and the death of 2 infants.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Recent Videos
Related Content
